| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 7 |
| NetGPI | no | yes: 0, no: 7 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005681 | spliceosomal complex | 3 | 7 |
| GO:0032991 | protein-containing complex | 1 | 7 |
| GO:0140513 | nuclear protein-containing complex | 2 | 7 |
| GO:1990904 | ribonucleoprotein complex | 2 | 7 |
| GO:0005654 | nucleoplasm | 2 | 1 |
| GO:0005684 | U2-type spliceosomal complex | 4 | 1 |
| GO:0005686 | U2 snRNP | 5 | 1 |
| GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 1 |
| GO:0071004 | U2-type prespliceosome | 5 | 1 |
| GO:0071010 | prespliceosome | 4 | 1 |
| GO:0071013 | catalytic step 2 spliceosome | 3 | 1 |
| GO:0097525 | spliceosomal snRNP complex | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
| GO:0120114 | Sm-like protein family complex | 2 | 1 |
| GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: E9AS78
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000375 | RNA splicing, via transesterification reactions | 8 | 7 |
| GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 7 |
| GO:0000398 | mRNA splicing, via spliceosome | 8 | 7 |
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 8 |
| GO:0006396 | RNA processing | 6 | 8 |
| GO:0006397 | mRNA processing | 7 | 7 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 8 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 8 |
| GO:0008152 | metabolic process | 1 | 8 |
| GO:0008380 | RNA splicing | 7 | 7 |
| GO:0009987 | cellular process | 1 | 8 |
| GO:0016070 | RNA metabolic process | 5 | 8 |
| GO:0016071 | mRNA metabolic process | 6 | 7 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 8 |
| GO:0043170 | macromolecule metabolic process | 3 | 8 |
| GO:0044237 | cellular metabolic process | 2 | 8 |
| GO:0044238 | primary metabolic process | 2 | 8 |
| GO:0045292 | mRNA cis splicing, via spliceosome | 9 | 7 |
| GO:0046483 | heterocycle metabolic process | 3 | 8 |
| GO:0071704 | organic substance metabolic process | 2 | 8 |
| GO:0090304 | nucleic acid metabolic process | 4 | 8 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 8 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 8 |
| GO:0003723 | RNA binding | 4 | 8 |
| GO:0005488 | binding | 1 | 8 |
| GO:0097159 | organic cyclic compound binding | 2 | 8 |
| GO:1901363 | heterocyclic compound binding | 2 | 8 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 146 | 150 | PF00656 | 0.707 |
| CLV_NRD_NRD_1 | 224 | 226 | PF00675 | 0.556 |
| CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.590 |
| CLV_PCSK_PC1ET2_1 | 226 | 228 | PF00082 | 0.641 |
| DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.547 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.711 |
| LIG_IBAR_NPY_1 | 58 | 60 | PF08397 | 0.607 |
| LIG_LIR_Gen_1 | 210 | 217 | PF02991 | 0.669 |
| LIG_LIR_Nem_3 | 114 | 120 | PF02991 | 0.645 |
| LIG_LIR_Nem_3 | 210 | 216 | PF02991 | 0.670 |
| LIG_PCNA_yPIPBox_3 | 26 | 34 | PF02747 | 0.378 |
| LIG_PTB_Apo_2 | 55 | 62 | PF02174 | 0.607 |
| LIG_SH2_CRK | 74 | 78 | PF00017 | 0.517 |
| LIG_SH2_NCK_1 | 4 | 8 | PF00017 | 0.733 |
| LIG_SH2_SRC | 147 | 150 | PF00017 | 0.706 |
| LIG_SH2_SRC | 182 | 185 | PF00017 | 0.781 |
| LIG_SH2_STAP1 | 213 | 217 | PF00017 | 0.654 |
| LIG_SH2_STAT3 | 124 | 127 | PF00017 | 0.650 |
| LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.742 |
| LIG_SH2_STAT5 | 33 | 36 | PF00017 | 0.553 |
| LIG_SH2_STAT5 | 37 | 40 | PF00017 | 0.508 |
| LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.517 |
| LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.517 |
| LIG_SH3_3 | 145 | 151 | PF00018 | 0.488 |
| MOD_CK1_1 | 167 | 173 | PF00069 | 0.660 |
| MOD_CK2_1 | 126 | 132 | PF00069 | 0.749 |
| MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.698 |
| MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.782 |
| MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.665 |
| MOD_GlcNHglycan | 183 | 187 | PF01048 | 0.779 |
| MOD_GSK3_1 | 163 | 170 | PF00069 | 0.731 |
| MOD_GSK3_1 | 178 | 185 | PF00069 | 0.623 |
| MOD_N-GLC_1 | 157 | 162 | PF02516 | 0.716 |
| MOD_NEK2_1 | 77 | 82 | PF00069 | 0.513 |
| MOD_PIKK_1 | 102 | 108 | PF00454 | 0.684 |
| MOD_PKA_2 | 85 | 91 | PF00069 | 0.691 |
| MOD_Plk_2-3 | 143 | 149 | PF00069 | 0.708 |
| MOD_Plk_4 | 143 | 149 | PF00069 | 0.724 |
| TRG_ENDOCYTIC_2 | 213 | 216 | PF00928 | 0.652 |
| TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.516 |
| TRG_ENDOCYTIC_2 | 74 | 77 | PF00928 | 0.517 |
| TRG_ER_diArg_1 | 225 | 228 | PF00400 | 0.635 |
| TRG_ER_diArg_1 | 51 | 54 | PF00400 | 0.517 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PET4 | Leptomonas seymouri | 51% | 100% |
| A0A3S7WVH7 | Leishmania donovani | 91% | 100% |
| A4HA73 | Leishmania braziliensis | 78% | 100% |
| A4HYE5 | Leishmania infantum | 91% | 100% |
| D0A0T0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 95% |
| Q4QD88 | Leishmania major | 93% | 100% |